Active	Status	Sponsor type	Region	Phase	Filter
6 Active 0 Inactive 6 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

6 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Tirumani, Anuritha
VICTORION-1 PREVENT, NCT05739383: A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.	Active, not recruiting	3	14013	Europe, Canada, US, RoW	Inclisiran sodium 300 mg (equivalent to 284 mg inclisiran) in 1.5 mL, KJX839, Placebo in 1.5ml	Novartis Pharmaceuticals	Primary Prevention of Atherosclerotic Cardiovascular Disease	04/29	04/29
ABRUPT2, NCT04356859: The Acute Burn ResUscitation Multicenter Prospective Trial	Recruiting	N/A	400	Canada, US	Albumin Human, albumin	American Burn Association, United States Department of Defense	Burn Injury	08/25	09/25
MAPLE, NCT04793360: Molecular Assessment and Profiling of Liver Transplant Recipients	Active, not recruiting	N/A	1500	US	LiverCare	CareDx	Liver Transplantation, Biomarkers	12/27	03/28
NCT05208489: Direct Peritoneal Resuscitation for Intra-abdominal Catastrophes	Recruiting	N/A	108	US	there is no intervention involved in this study	New York Medical College	Intestinal Perforation, Intestinal Obstruction, Trauma Abdomen	06/22	06/23
Williams, Aerial
ABRUPT2, NCT04356859: The Acute Burn ResUscitation Multicenter Prospective Trial	Recruiting	N/A	400	Canada, US	Albumin Human, albumin	American Burn Association, United States Department of Defense	Burn Injury	08/25	09/25
Winski, Francis
ABRUPT2, NCT04356859: The Acute Burn ResUscitation Multicenter Prospective Trial	Recruiting	N/A	400	Canada, US	Albumin Human, albumin	American Burn Association, United States Department of Defense	Burn Injury	08/25	09/25